Paul Dickman

Author PubWeight™ 14.35^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children's Oncology Group Study.	J Clin Oncol	2009	2.44
2	Real-world cost-effectiveness in chronic myeloid leukemia: the price of success during four decades of development from non-targeted treatment to imatinib.	Leuk Lymphoma	2014	1.43
3	Enhanced T-cell immunity to osteosarcoma through antibody blockade of PD-1/PD-L1 interactions.	J Immunother	2015	1.04
4	Ovarian epithelial neoplasia after hormonal infertility treatment: long-term follow-up of a historical cohort in Sweden.	Fertil Steril	2008	1.02
5	A proposed method to adjust for selection bias in cohort studies.	Am J Epidemiol	2010	0.99
6	Stage at diagnosis and mortality in women with pregnancy-associated breast cancer (PABC).	Breast Cancer Res Treat	2013	0.91
7	A method to visualize and adjust for selection bias in prevalent cohort studies.	Am J Epidemiol	2011	0.90
8	Characterization of the chromosome 1q41q42.12 region, and the candidate gene DISP1, in patients with CDH.	Am J Med Genet A	2010	0.90
9	BIRC5 expression is a poor prognostic marker in Ewing sarcoma.	Pediatr Blood Cancer	2012	0.89
10	Rebuttal to editorial saying cancer survival statistics are misleading.	BMJ	2011	0.82
11	Pathobiologic markers of the ewing sarcoma family of tumors: state of the art and prediction of behaviour.	Sarcoma	2010	0.82
12	Mortality after pediatric lung transplantation: autopsies vs. clinical impression.	Pediatr Pulmonol	2004	0.79
13	MAOA haplotypes associated with thrombocyte-MAO activity.	BMC Genet	2005	0.78
14	Sinonasal malignancies in Sweden 1960-2010; a nationwide study of the Swedish population.	Rhinology	2015	0.78
15	[Cancer researchers need statistical uncertainty!].	Lakartidningen	2004	0.75